Literature DB >> 33206398

LRRK2 at the pre-synaptic site: A 16-years perspective.

Francesca Pischedda1, Giovanni Piccoli1.   

Abstract

Parkinson's disease is a common neurodegenerative disorder and is clinically characterized by bradykinesia, rigidity, and resting tremor. Missense mutations in the leucine-rich repeat protein kinase-2 gene (LRRK2) are a recognized cause of inherited Parkinson's disease. The physiological and pathological impact of LRRK2 is still obscure, but accumulating evidence indicates that LRRK2 orchestrates diverse aspects of membrane trafficking, such as membrane fusion and vesicle formation and transport along actin and tubulin tracks. In the present review, we focus on the special relation between LRRK2 and synaptic vesicles. LRRK2 binds and phosphorylates key actors within the synaptic vesicle cycle. Accordingly, alterations in dopamine and glutamate transmission have been described upon LRRK2 manipulations. However, the different modeling strategies and phenotypes observed require a critical approach to decipher the outcome of LRRK2 at the pre-synaptic site.
© 2020 International Society for Neurochemistry.

Entities:  

Keywords:  LRRK2; Parkinson's disease; presynaptic bouton; synaptic vesicle

Year:  2021        PMID: 33206398     DOI: 10.1111/jnc.15240

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

Review 1.  Lysosomal Pathogenesis of Parkinson's Disease: Insights From LRRK2 and GBA1 Rodent Models.

Authors:  Mattia Volta
Journal:  Neurotherapeutics       Date:  2022-09-09       Impact factor: 6.088

2.  Novel Macrocyclic LRRK2 Inhibitors for Treating Parkinson's Disease.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2022-01-03       Impact factor: 4.345

3.  Novel N-Heteroaryl Quinazolin-2-amine Derivatives as LRRK2 Inhibitors for Treating Parkinson's Disease.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-06-09       Impact factor: 4.632

4.  Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synuclein.

Authors:  Charlotte F Brzozowski; Baraa A Hijaz; Vijay Singh; Nolwazi Z Gcwensa; Kaela Kelly; Edward S Boyden; Andrew B West; Deblina Sarkar; Laura A Volpicelli-Daley
Journal:  Acta Neuropathol Commun       Date:  2021-11-08       Impact factor: 7.801

5.  Aberrant Patterns of Sensory-Evoked Activity in the Olfactory Bulb of LRRK2 Knockout Mice.

Authors:  Andrea Maset; Marco Albanesi; Antonio di Soccio; Martina Canova; Marco Dal Maschio; Claudia Lodovichi
Journal:  Cells       Date:  2021-11-17       Impact factor: 6.600

6.  LRRK2-G2019S mice display alterations in glutamatergic synaptic transmission in midbrain dopamine neurons.

Authors:  Olga Skiteva; Ning Yao; Giacomo Sitzia; Karima Chergui
Journal:  J Neurochem       Date:  2022-02-27       Impact factor: 5.546

7.  Multiple Pathways of LRRK2-G2019S/Rab10 Interaction in Dopaminergic Neurons.

Authors:  Alison Fellgett; C Adam Middleton; Jack Munns; Chris Ugbode; David Jaciuch; Laurence G Wilson; Sangeeta Chawla; Christopher J H Elliott
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.